消肿止痛液治疗具有出血风险的深静脉血栓的血清指标变化(2)
参考文献
[1]Qian K , Xu J , Wan H ,et al.Impact of genetic polymorphisms in thrombin activatable fibrinolysis inhibitor (TAFI) on venous thrombosis disease: A meta-analysis [J].Gene,2015 ,569 (2): 173-181
[2]Praeger AJ,Westbrook AJ,Nichol AD,et al.Deep vein throm-bosis and pulmonary embolus in patients with traumatic brain injury:a prospective observational study[J].Crit Care Resusc,2012,14(1):10-13
[3]Ciuti G,Grifoni E,Pavellini A.Pavellini AIncidence and char-acteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting [J].Thromb Res,2012,11(14):231-234
[4]Kearon C,Kahn SR,Agnelli G,et al.Antithrombotic therapy for venous thromboembolic disease:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines(8th Edition)[J].Chest,2008,133(6 Suppl):454-455
[5]中華医学会外科学分会血管外科学组.深静脉血栓形成和治疗指南[J].中华外科杂志,2012,50(7):611-614
[6]崔桂萍 , 郭海枫 , 薛凯 .急性颅脑损伤后部分凝血指标变化的研究[J].检验医学,2007,22(2):185-187
[7]Palareti G, Legnani C, Cosmi B, et al.Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study[J].Int J Lab Hematol, 2015,12(10):1111
[8]Alons IM, Jellema K, Wermer MJ, et al.D-dimer for the exclusion of cerebral venous thrombosis: a meta-analysis of low risk patients with isolated headache[J].BMC Neurol, 2015,15(1):118, 百拇医药(郑永恒 王纪臣 张学慧 王晓军)
[1]Qian K , Xu J , Wan H ,et al.Impact of genetic polymorphisms in thrombin activatable fibrinolysis inhibitor (TAFI) on venous thrombosis disease: A meta-analysis [J].Gene,2015 ,569 (2): 173-181
[2]Praeger AJ,Westbrook AJ,Nichol AD,et al.Deep vein throm-bosis and pulmonary embolus in patients with traumatic brain injury:a prospective observational study[J].Crit Care Resusc,2012,14(1):10-13
[3]Ciuti G,Grifoni E,Pavellini A.Pavellini AIncidence and char-acteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting [J].Thromb Res,2012,11(14):231-234
[4]Kearon C,Kahn SR,Agnelli G,et al.Antithrombotic therapy for venous thromboembolic disease:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines(8th Edition)[J].Chest,2008,133(6 Suppl):454-455
[5]中華医学会外科学分会血管外科学组.深静脉血栓形成和治疗指南[J].中华外科杂志,2012,50(7):611-614
[6]崔桂萍 , 郭海枫 , 薛凯 .急性颅脑损伤后部分凝血指标变化的研究[J].检验医学,2007,22(2):185-187
[7]Palareti G, Legnani C, Cosmi B, et al.Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study[J].Int J Lab Hematol, 2015,12(10):1111
[8]Alons IM, Jellema K, Wermer MJ, et al.D-dimer for the exclusion of cerebral venous thrombosis: a meta-analysis of low risk patients with isolated headache[J].BMC Neurol, 2015,15(1):118, 百拇医药(郑永恒 王纪臣 张学慧 王晓军)
参见:首页 > 医疗版 > 疾病专题 > 心血管科 > 下肢深静脉血栓